Arbovax's Dengue vaccine is now ready for clinical trials :: Editor's Blog at WRAL Tech Wire | Research from the NC Agricultural Research Service | Scoop.it
The Raleigh company, a spinout from North Carolina State University, announced it has validated its vaccine technology in animal tests and will now move on to phase I clinical trials of its Dengue vaccine candidate.